SOCS2 and acute myeloid leukemia: Overexpression of others genes included in our signature, MSI2 (Musashi 2) and SOCS2 (Suppressor of cytokines signaling 2), predicted unfavorable outcome in AML and chronic myeloid leukemia (CML) [17,18].